New

Bad Blood: Secrets and Lies in a Silicon Valley Startup

Regular price $16.86
Unit price
per
Compare to estimated retail price: S$39.90  

Silicon Valley startup's rise and scandalous fall.

If you're drawn to the drama of high-stakes corporate intrigue, "Bad Blood" is your kind of read. It's like watching a slow-motion car crash you can’t look away from, filled with ambition, deception, and a cautionary tale of what happens when the pursuit of success overrides integrity. John Carreyrou delivers a masterclass in investigative journalism that's as thrilling as any fiction.

  • Los Angeles Times Book Prize Nominee for Current Interest (2018)
  • Financial Times Business Book of the Year (2018)
  • Goodreads Choice Award Nominee for Nonfiction (2018)
Note: While we do our best to ensure the accuracy of cover images, ISBNs may at times be reused for different editions of the same title which may hence appear as a different cover.
New

Bad Blood: Secrets and Lies in a Silicon Valley Startup

Regular price $16.86
Unit price
per
Compare to estimated retail price: S$39.90  
Condition guide

Special Offer

Buy 3, Get Another Free On All Items Under S$10 Storewide

Discount applied automatically when you add them to your cart.

ISBN: 9781509868087
Authors: John Carreyrou
Publisher: Picador
Date of Publication: 2019-01-01
Format: Paperback
Related Collections: History, Science, Biographies & Memoirs, Business
Goodreads rating: 4.41
(rated by 279830 readers)

Description

Winner of the Financial Times/McKinsey Business Book of the Year Award 2018, the full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
 

Silicon Valley startup's rise and scandalous fall.

If you're drawn to the drama of high-stakes corporate intrigue, "Bad Blood" is your kind of read. It's like watching a slow-motion car crash you can’t look away from, filled with ambition, deception, and a cautionary tale of what happens when the pursuit of success overrides integrity. John Carreyrou delivers a masterclass in investigative journalism that's as thrilling as any fiction.

  • Los Angeles Times Book Prize Nominee for Current Interest (2018)
  • Financial Times Business Book of the Year (2018)
  • Goodreads Choice Award Nominee for Nonfiction (2018)
Note: While we do our best to ensure the accuracy of cover images, ISBNs may at times be reused for different editions of the same title which may hence appear as a different cover.